PRE 14A

PRE 14A

Company: LEXICON PHARMACEUTICALS, INC.
Filed: March 11, 2022
Period of Report: March 11, 2022
Accession Number: 0001062822-22-000008

View Document ↗ View on SEC.gov ↗